Froimson Mark — SEC Form 4 filings

SEC reporting owner CIK 1709050. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-06-13 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Pacira BioSciences, Inc. (PCRX)Director51 leg · 1,400 sh · $16,2121 leg · 500 sh · $10,9056

Form 4 filings — Froimson Mark

FiledFormIssuerReported transactionsSource
2026-06-124Pacira BioSciences, Inc. (PCRX)Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0EDGAR
2026-03-194Pacira BioSciences, Inc. (PCRX)Sale (S): 500 @ $21.81EDGAR
2025-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0EDGAR
2024-08-124Pacira BioSciences, Inc. (PCRX)Purchase (P): 1,400 @ $11.58EDGAR
2024-06-134Pacira BioSciences, Inc. (PCRX)Grant/award (A): 5,230 @ $0 · Grant/award (A): 12,179 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1709050 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →